Cannabis Law Report

DECEMBER 17, 2021

Deletion Syndrome – Global Market Insights, Epidemiology and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. deletion syndrome in the 7MM covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2018 to 2030. Country-Wise Epidemiology.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

Cannabis Law Report

JUNE 30, 2021

According to the Lancet Commission, mental health disorders are on the rise in every country worldwide, and the resulting lost productivity will cost the global economy $16 trillion by 2030. Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

OCTOBER 1, 2021

We are excited to be developing and bringing to market treatments addressing cluster headaches, neuropathic pain and range of mental health conditions, including depression, anxiety and PTSD, and related disorders.”. billion in 2019 and projected to reach near US$25 billion by 2030. billion industry by 2027.

Treatment 52

Treatment Conditions Media 52

Cannabis Law Report

FEBRUARY 3, 2022

DUBLIN–(BUSINESS WIRE)–The “Global Cannabis Market- Market Size & Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. million by 2030 at a CAGR of 23.9%, 2021-2030. Growing Adoption of Medical Cannabis for the Treatment of Chronic Compounds. Restraints.

Indica 52

Indica Oil Legalization Research and Development 52

Cannabis Law Report

JUNE 20, 2021

On June 18, 2021, Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering. . trillion by 2030.

Research and Development 98

Research and Development Therapy Treatment Access 98

MGC Pharma

FEBRUARY 22, 2018

According to the Australian Bureau of Statistics, the number of people aged 65 years or older is expected to exceed the number of children aged 14 and below by as soon as 2030. of respondents who received Medical Cannabis treatment reported improvement in their condition and significant reductions to pain levels.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

Cannabis Law Report

JUNE 19, 2021

June 18, 2021 (Chicago) — Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences ’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering.

Research and Development 105

Research and Development Therapy Treatment Access 105